Casdin Capital’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,650,000
| Closed | -$39.5M | – | 49 |
|
|
2021
Q4 | $39.5M | Buy |
2,650,000
+550,000
| +26% | +$8.21M | 1.11% | 27 |
|
|
2021
Q3 | $54M | Buy |
2,100,000
+875,000
| +71% | +$22.5M | 1.34% | 27 |
|
|
2021
Q2 | $31.9M | Sell |
1,225,000
-75,000
| -6% | -$1.96M | 0.81% | 32 |
|
|
2021
Q1 | $45.9M | Buy |
1,300,000
+355,000
| +38% | +$12.5M | 1.37% | 19 |
|
|
2020
Q4 | $23.9M | Hold |
945,000
| – | – | 0.71% | 32 |
|
|
2020
Q3 | $35.6M | Buy |
945,000
+320,000
| +51% | +$12.1M | 1.6% | 20 |
|
|
2020
Q2 | $26.8M | Buy |
625,000
+125,000
| +25% | +$5.35M | 1.58% | 21 |
|
|
2020
Q1 | $9.72M | Buy |
+500,000
| New | +$9.72M | 1.03% | 29 |
|